Lumos Diagnostics has kicked off a key paediatric study in the US for its FebriDx rapid diagnostic test, marking a ...

The ASX healthcare sector broke its October winning streak with the S&P/ASX Health Care Index (XHJ) falling 1.74% for the ...

The latest quarterly reporting season is underway, with investors tuning in to see how ASX-listed companies performed during ...

Special Report: Lumos Diagnostics has inked an agreement with WellStreet Urgent Care to expand the use of its FebriDx rapid ...

The ASX 200 slid 64 points today, retreating as traders took profits on yesterday’s all-time closing high and gold prices ...

EINPresswire/ -- Big Ben Medical, a leading provider of innovative healthcare solutions for Urgent Cares, is pleased to announce that it has signed a distribution agreement with binx health, a ...

Anbio Biotechnology is a medical device firm develops in-vitro diagnostics, with stock volatility & thin public float. Read ...

Building upon rapid adoption of ReperioKit™ across all 50 states, Reperio expands its ReperioCare™ telehealth services nearly nationwide to make "screen and see a provider in an hour" a reality for ...

We provide services to Adult (ages 18-64) that are seeking Behavioral Health Services, Mental health Counseling and Outpatient Substance Use Treatment. This includes Mental Health Evaluations, ...

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) just unveiled an announcement. Lumos Diagnostics has made significant strides in FY25, transitioning ...

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) just unveiled an update. Lumos Diagnostics reported a steady revenue of US$3.4 million for the first ...

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.